Towards the gene therapy of LAD-I immunodeficient patients

被引：0
|
作者：
Almarza, E. [1 ,2 ,3 ]
Mesa-Nunez, C. [1 ,2 ,3 ]
Damian, C. [1 ,2 ,3 ]
Leon-Rico, D. [1 ,2 ,3 ]
Aldea, M. [1 ,2 ,3 ]
Carrascoso, C. [1 ,2 ,3 ]
Lozano, M. L. [1 ,2 ,3 ]
Guenechea, G. [1 ,2 ,3 ]
Thrasher, A. J. [4 ]
Bueren, J. A. [1 ,2 ,3 ]
机构：
[1] Ctr Invest Energet Medioambientales & Tecnol CIEM, Div Haematopoiet Innovat Therapies, Madrid 28040, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28040, Spain
[3] Fdn Jimenez Diaz IIS FJD UAM, Inst Invest Sanitaria, Adv Therapies Unit, Madrid, Spain
[4] Univ Coll London ICH UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P010
引用
收藏
页码：A20 / A21
页数：2
相关论文
共 50 条
  • [1] Development of new lentiviral vectors for the gene therapy of LAD-I
    Leon-Rico, D.
    Aldea, M.
    Santilli, G.
    Thrasher, A. J.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2013, 24 (12) : A39 - A39
  • [2] Comprehensive preclinical studies for the gene therapy of patients with leukocyte adhesion deficiency type I (LAD-I)
    Almarza, E.
    Mesa-Nunez, C.
    Damian, C.
    Diez-Cabezas, B.
    Fernandez-Garcia, M.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A28 - A28
  • [3] Disrupting the 'neutrostat' in LAD-I
    Kirsty Minton
    Nature Reviews Immunology, 2014, 14 (5) : 286 - 286
  • [4] Gene Therapy of Patients with Leukocyte Adhesion Deficiency Type I (LAD-I): Preclinical Studies and Clinical Trial Design
    Almarza, Elena
    Mesa-Nunez, Cristina
    Damian, Carlos
    Diez-Cabezas, Begona
    Fernandez-Garcia, Maria
    Lozano, MLuz
    Rio, Paula
    Yanez, Rosa M.
    Beard, Brian
    Sevilla, Julian
    Schwartz, Jonathan D.
    Bueren, Juan A.
    MOLECULAR THERAPY, 2019, 27 (04) : 392 - 392
  • [5] LAD-I: a magnesium sensing deficiency?
    Marti, A.
    Lotscher, J.
    Grahlert, J.
    Hess, C.
    SWISS MEDICAL WEEKLY, 2022, 152 : 18S - 19S
  • [6] Lentiviral Vector-Mediated Gene Complementation for the Diagnosis of LAD-I
    Mesa-Nunez, Cristina
    Damian, Carlos
    Gilmour, Kimberly
    Sanchez, Rebeca
    Alberquilla, Omaira
    Segovia, Jose C.
    Booth, Claire
    Bueren, Juan A.
    Ip, Winnie
    Almarza, Elena
    MOLECULAR THERAPY, 2020, 28 (04) : 176 - 177
  • [7] Stable transduction of long-term HSCs under optimized GMP-conditions for the gene therapy of LAD-I patients
    Mesa-Nunez, C.
    Damian, C.
    Fernandez-Garcia, M.
    Diez-Cabezas, B.
    Lozano, M. L.
    Rio, P.
    Yanez, R.
    Law, K.
    Beard, B.
    Schwartz, J. D.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2019, 30 (11) : A86 - A87
  • [8] Regulated CD18 expression in the haematopoietic gene therapy of leukocyte adhesion deficiency type I (LAD-I)
    Mesa-Nunez, C.
    Damian, C.
    Leon-Rico, D.
    Aldea, M.
    Thrasher, A. J.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A22 - A22
  • [9] Gene Therapy for Lad-I Immunodeficiency: Preclinical Evaluation of HSC Transduction Under Optimized GMP-Conditions
    Almarza, Elena
    Mesa-Nunez, Cristina
    Damian, Carlos
    Fernandez-Garcia, Maria
    Diez-Cabezas, Begona
    Lozano, M. Luz
    Rio, Paula
    Yanez, Rosa M.
    Law, Ken
    Beard, Brian C.
    Schwartz, Jonathan D.
    Bueren, Juan A.
    BLOOD, 2019, 134
  • [10] Prenatal Diagnosis of LAD-I on Cord Blood by Flowcytometry
    Manisha Rajan Madkaikar
    Maya Gupta
    Meghana Rao
    Kanjaksha Ghosh
    The Indian Journal of Pediatrics, 2012, 79 : 1605 - 1609
12345